After reports that most donations made to the big advocacy group came from drug makers in recent years, the National Alliance on Mental Illness (NAMI) agreed to disclose its funding sources. The disclosure, however, came after protracted criticism of NAMI for coordinating lobbying efforts with drug makers and pushing legislation that also benefits the pharma industry.